PE html>
<html>
<head>
<title>George Cruikshank Introduction of the Gout (1818)</title>
<style>
            body {
                font-family: Arial, sans-serif;
                margin: 40px;
                display: flex;
            }
            img {
                max-width: 30%;
                height: 100%;
                margin-right: 20px;
            }
            .content {
                max-width: 70%;
            }
</style>
</head>
<body>
<img src="../images/GeorgeCruikshankIntroductionoftheGout1818.jpg" alt="George Cruikshank Introduction of the Gout (1818)">
<div class="content">
<h1>George Cruikshank Introduction of the Gout (1818)</h1>

<h2>[a] Artist/ Group/Tribe</h2>
<p>George Cruikshank (1792–1878) was a leading British caricaturist and printmaker, renowned for piercing satirical etchings that targeted politics, medicine, and manners of Regency and early Victorian Britain. Trained in the London print trade and influenced by William Hogarth and James Gillray, Cruikshank’s hand-coloured etchings circulated widely through print sellers’ shops. His art fused comic invention with moral critique, relishing exaggeration and emblematic signs that made complex social ideas legible to a broad public. He later illustrated literary works, but his early satires, including this image, remain central to his reputation.</p>

<h2>[b] Historical and Socio-Cultural context (time-frame)</h2>
<p>Created in 1818, the work belongs to the Regency era, a period marked by post-Napoleonic uncertainty, intensifying consumer culture, and a thriving market for graphic satire. Gout, already stereotyped as a “gentleman’s disease,” symbolized elite overindulgence in red meats, shellfish, sugary desserts, and fortified wines like port. Urban coffee houses, clubs, and private dinners reinforced conspicuous consumption. Medical thought was transitioning from humoral models toward chemical and anatomical explanations. Simultaneously, print culture democratized commentary: affordable caricatures allowed middle-class viewers to mock aristocratic excess and to reflect on the moral economy of health.</p>

<h2>[c] Symbolism and/ or iconography</h2>
<p>The demon personifying “Gout” grips the gentleman’s inflamed great toe with blacksmith tongs, an allegory of acute podagra’s burning pain. The glistening decanters, citrus, sweets, and lavish fruit pyramid connote purine- and sugar-rich indulgence; the upholstered chair and ornate clock index wealth and leisure. The clouds and curlicues around the foot suggest radiating throbs, while the subject’s complacent posture and raised glass dramatize denial—pleasure maintained at the threshold of suffering. Cruikshank’s iconography links bodily affliction to moral failing, a stock trope in eighteenth–nineteenth-century satire that made disease a public theater of character.</p>

<h2>[d] Stylistic Significance (elements of art/ principles of design)</h2>
<p>Executed as a hand-coloured etching, the image relies on emphatic contour lines, compressed space, and a theatrical mise-en-scène. Caricatural disproportion—ample body, tiny demonic tormentor—foregrounds narrative clarity. A warm palette of reds, yellows, and oranges concentrates around food, drink, and the inflamed toe, guiding the eye in a triangular circuit of cause and effect. Patterned floor swirls rhythmically echo the pulsation of pain. Balance is asymmetrical: the gentleman’s mass anchors the left, while the darting diagonal of the demon and tongs propels action to the right, energizing the comic cruelty of the scene.</p>

<h2>[e] Social / Cultural Inequities</h2>
<p>Historically, gout was framed as aristocratic, masking structural determinants: access to rich diets, sedentary occupations, and medical care. Today, however, gout disproportionately affects populations experiencing socioeconomic deprivation, food deserts, and limited preventive care. The satirical blame placed on individual vice obscures systemic drivers—pricing of healthy foods, alcohol marketing, and inequities in primary care and urate-lowering therapy access—that shape disease distribution more than personal moral character.</p>

<h2>[f] Description of Disease & Etiology</h2>
<p>Gout is an inflammatory arthritis caused by deposition of monosodium urate crystals in joints and soft tissues, driven by chronic hyperuricemia. Uric acid results from purine metabolism; hyperuricemia reflects overproduction, underexcretion (most common), or both. Genetic variants (e.g., in SLC2A9/GLUT9, ABCG2, URAT1/SLC22A12) modulate renal and intestinal urate handling. Triggers include alcohol—especially beer and spirits—purine-rich meats and seafood, fructose-sweetened beverages, dehydration, diuretics, renal impairment, and metabolic syndrome. Crystal engagement of the NLRP3 inflammasome leads to IL‑1β release, neutrophil influx, and the classic acute flare.</p>

<h2>[g] Pathology Signs/Signifiers of Illness</h2>
<p>Clinically, gout often presents as podagra: sudden nocturnal pain, erythema, warmth, and exquisite tenderness at the first metatarsophalangeal joint. Recurrent flares may progress to polyarticular attacks, tophus formation, and chronic erosive arthropathy. Comorbidities include hypertension, CKD, obesity, diabetes, and cardiovascular disease. In the image, the glowing toe, tormenting tongs, and indulgent spread function as visual signifiers of an acute flare precipitated by lifestyle factors, aligning symptom with symbol.</p>

<h2>[h] Treatment</h2>
<p>Acute flares are treated with NSAIDs, low-dose colchicine, or corticosteroids; IL‑1 inhibitors are options in refractory cases. Long-term management targets serum urate below 6 mg/dL (below 5 mg/dL for tophaceous disease) using xanthine oxidase inhibitors (allopurinol first-line; febuxostat when appropriate). Uricosurics or pegloticase serve select indications. Prophylaxis with low-dose colchicine or NSAIDs is recommended during urate-lowering initiation. Lifestyle counseling includes moderation of alcohol (particularly beer/spirits), reduction of purine-rich meats and certain seafoods, limiting fructose, weight loss, hydration, and review of hyperuricemia-inducing drugs.</p>

<h2>[i] Social Determinants of Illness</h2>
<p>Dietary environments, income, work schedules, and insurance status condition both risk and adherence to therapy. Communities with limited access to fresh foods and primary care experience higher flare rates and undertreatment. Historical trade networks that popularized sugar and fortified wines help explain the artwork’s setting, while contemporary marketing and pricing policies perpetuate exposure. Culturally tailored education, affordable medications, and primary-care algorithms for treat-to-target urate control are essential to redress these inequities.</p>

<h2>[j] References and Citations</h2>
<ul>
<li>Encyclopaedia Britannica. George Cruikshank. https://www.britannica.com/biography/George-Cruikshank</li>
<li>British Museum Collection Online. George Cruikshank, Introduction of the Gout (1818). https://www.britishmuseum.org/collection/search?searchTerm=Introduction%20of%20the%20Gout</li>
<li>Wellcome Collection. Introduction of the Gout (image and catalogue). https://wellcomecollection.org/works?query=Introduction%20of%20the%20Gout</li>
<li>Dalbeth N, Gosling AL, Gaffo A, Abhishek A. Gout. The Lancet. 2021;397(10287):1843–1855. doi:10.1016/S0140-6736(21)00569-9</li>
<li>FitzGerald JD et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care & Research. 2020;72(6):744–760. doi:10.1002/acr.24180</li>
<li>Neogi T. Gout. New England Journal of Medicine. 2011;364:443–452. doi:10.1056/NEJMcp1001124</li>
<li>Martinon F, Pétrilli V, Mayor A, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440:237–241. doi:10.1038/nature04516</li>
<li>Porter R, Rousseau GS. Gout: The Patrician Malady. Yale University Press; 1998.</li>
<li>Kuo CF, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 2015;11:649–662. doi:10.1038/nrrheum.2015.91</li>
<li>World Health Organization. Social determinants of health. https://www.who.int/health-topics/social-determinants-of-health</li>
</ul>
</div>
</body>
</ht